See Our Current Investments

COVID 19

October 15th

DXB to run a Phase III COVID-19 Study in Australia
DXB announces approval for Phase III COVID-19 trials in India

September 24th 2021

DXB announces approval for Phase III COVID-19 trials in India
Bod Australia outlines strong revenue growth

April 22nd 2021

Bod Australia outlines strong revenue growth
Can BDA’s medical cannabis product treat long-COVID symptoms?

March 18th 2021

Can BDA’s medical cannabis product treat long-COVID symptoms?
Australian stock market still the best performing in the world

March 12th 2021

Australian stock market still the best performing in the world
Is Australia spending our grandchildren’s future?

February 19th 2021

Is Australia spending our grandchildren’s future?
Achiko emerges as strong Covid-19 beneficiary

December 17th 2020

Achiko emerges as strong Covid-19 beneficiary
Brexit and COVID impact markets while Airbnb gets set to list

December 8th 2020

Brexit and COVID impact markets while Airbnb gets set to list
Strong results show Alexium remains resilient in tough market

October 30th 2020

Strong results show Alexium remains resilient in tough market

Subscribe for updates on our small cap, ASX listed biotech portfolio.

Thanks for subscribing!

X